Not Tagged
Not Tagged
['gi ']
 although neoadjuvant systemic therapy offers advantages as compared to adjuvant in certain tumor types, i would say data in gi cancers presented at asco showed us that sometimes adjuvant is still the standard of care.
I treat patients with sarcoma and gastrointestinal malignancies at Hospital Israelita Albert Einstein, and serve as chair of  the LACOG sarcoma group